X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs NATCO PHARMA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD NATCO PHARMA BIOCON LTD/
NATCO PHARMA
 
P/E (TTM) x 84.7 30.9 274.1% View Chart
P/BV x 8.0 23.4 34.1% View Chart
Dividend Yield % 0.2 0.5 31.8%  

Financials

 BIOCON LTD   NATCO PHARMA
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
NATCO PHARMA
Mar-14
BIOCON LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,162877 132.5%   
Low Rs483424 113.9%   
Sales per share (Unadj.) Rs194.6223.4 87.1%  
Earnings per share (Unadj.) Rs34.431.1 110.7%  
Cash flow per share (Unadj.) Rs48.340.3 119.8%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %0.10.8 15.8%  
Book value per share (Unadj.) Rs241.9219.5 110.2%  
Shares outstanding (eoy) m200.0033.07 604.8%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x4.22.9 145.2%   
Avg P/E ratio x23.920.9 114.2%  
P/CF ratio (eoy) x17.016.1 105.5%  
Price / Book Value ratio x3.43.0 114.7%  
Dividend payout %2.916.1 18.1%   
Avg Mkt Cap Rs m164,44021,504 764.7%   
No. of employees `0009.2NA-   
Total wages/salary Rs m7,4701,128 662.4%   
Avg. sales/employee Rs Th4,213.9NM-  
Avg. wages/employee Rs Th809.0NM-  
Avg. net profit/employee Rs Th745.2NM-  
INCOME DATA
Net Sales Rs m38,9117,389 526.6%  
Other income Rs m1,571167 940.2%   
Total revenues Rs m40,4827,556 535.8%   
Gross profit Rs m9,7951,793 546.2%  
Depreciation Rs m2,772304 910.6%   
Interest Rs m260366 71.0%   
Profit before tax Rs m8,3341,290 646.1%   
Minority Interest Rs m16346 352.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,616309 523.5%   
Profit after tax Rs m6,8811,027 669.7%  
Gross profit margin %25.224.3 103.7%  
Effective tax rate %19.423.9 81.0%   
Net profit margin %17.713.9 127.2%  
BALANCE SHEET DATA
Current assets Rs m40,4773,681 1,099.5%   
Current liabilities Rs m16,7833,123 537.4%   
Net working cap to sales %60.97.6 805.5%  
Current ratio x2.41.2 204.6%  
Inventory Days Days6089 66.6%  
Debtors Days Days8359 141.2%  
Net fixed assets Rs m45,0737,685 586.5%   
Share capital Rs m1,000331 302.4%   
"Free" reserves Rs m47,3776,670 710.3%   
Net worth Rs m48,3777,259 666.5%   
Long term debt Rs m21,082955 2,207.8%   
Total assets Rs m93,94211,957 785.7%  
Interest coverage x33.14.5 730.9%   
Debt to equity ratio x0.40.1 331.3%  
Sales to assets ratio x0.40.6 67.0%   
Return on assets %7.611.7 65.2%  
Return on equity %14.214.2 100.5%  
Return on capital %12.620.7 60.8%  
Exports to sales %039.4 0.0%   
Imports to sales %05.7 0.0%   
Exports (fob) Rs mNA2,908 0.0%   
Imports (cif) Rs mNA421 0.0%   
Fx inflow Rs m12,9883,445 377.0%   
Fx outflow Rs m7,899703 1,123.9%   
Net fx Rs m5,0892,743 185.6%   
CASH FLOW
From Operations Rs m6,4001,440 444.4%  
From Investments Rs m-4,985-1,089 457.7%  
From Financial Activity Rs m-1,775-353 503.3%  
Net Cashflow Rs m-473-1 31,745.0%  

Share Holding

Indian Promoters % 40.4 52.0 77.6%  
Foreign collaborators % 20.6 1.5 1,401.4%  
Indian inst/Mut Fund % 8.4 7.8 107.1%  
FIIs % 10.7 16.6 64.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 26.0 76.5%  
Shareholders   109,995 25,395 433.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   STRIDES SHASUN LTD  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  WOCKHARDT LTD.  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Jan 23, 2018 03:34 PM

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD 8-QTR ANALYSIS

COMPARE BIOCON LTD WITH

MARKET STATS